Franco A. Felizarta
Expertise in
10
conditions

Dr. Franco A. Felizarta

Infectious Disease
3535 San Dimas St, Ste 24, 
Bakersfield, CA 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
3535 San Dimas St, Ste 24, 
Bakersfield, CA 

Overview

I work in partnership with patients, offering high-quality, and individualized care with compassion. I believe communication and collaboration with patients is the foundation for effective relationships. Please contact our office with additional questions. We look forward to hearing from you.

Dr. Felizarta is highly rated in 10 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, HIV/AIDS, Hepatitis C, and Hepatitis.

His clinical research consists of co-authoring 27 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

University Of Phillippines College Of Medicine

Specialties

Infectious Disease

Licenses

Internal Medicine in CA

Board Certifications

Internal Medicine
Internal Medicine (Sub: Infectious Disease)

Hospital Affiliations

Dignity Health – Memorial Hospital

Languages Spoken

English
Filipino
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Nippon Life
  • INSURANCE PLAN
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 16 Less Insurance Carriers -

Locations

Franco Felizarta, MD Private Practice
3535 San Dimas St, Ste 24, Bakersfield, CA 93301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Device, Diagnostic test
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
A Phase IIb, Randomized, Double-blind, Parallel-group Study to Assess the Efficacy, Safety, Tolerability, and Resistance Profile of GSK3640254 in Combination With Dolutegravir Compared to Dolutegravir Plus Lamivudine in HIV-1 Infected, Treatment-naïve Adults
Enrollment Status: Terminated
Publish Date: December 14, 2023
Intervention Type: Drug
Study Drugs: GSK3640254, Dolutegravir, Lamivudine
Study Phase: Phase 2
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
Enrollment Status: Completed
Publish Date: February 16, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
Enrollment Status: Terminated
Publish Date: September 11, 2018
Intervention Type: Drug
View 4 Less Clinical Trials

27 Total Publications

Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.
Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.
Journal: Nature medicine
Published: October 18, 2024
Similar Doctors
Expertise in
6
conditions
Dr. Royce Johnson
Infectious Disease
Expertise in
6
conditions
Dr. Royce Johnson
Infectious Disease

Kern Medical

1700 Mount Vernon Ave, 
Bakersfield, CA 
 (88.4 miles away)
661-326-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Royce Johnson is an Infectious Disease provider in Bakersfield, California. Dr. Johnson is highly rated in 6 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Meningitis, Brucellosis, Hepatitis C, and Orchiectomy.

Expertise in
3
conditions
Dr. Rasha Kuran
Infectious Disease
Expertise in
3
conditions
Dr. Rasha Kuran
Infectious Disease

Adventist Health Physicians Network

9330 Stockdale Hwy, 
Bakersfield, CA 
 (80.5 miles away)
661-664-2200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rasha Kuran is an Infectious Disease provider in Bakersfield, California. Dr. Kuran is highly rated in 3 conditions, according to our data. Her top areas of expertise are Coccidioidomycosis, Osteomyelitis, Meningitis, Syphilis, and Splenectomy.

Expertise in
24
conditions
Dr. Randolph Del Castillo Senining
Infectious Disease
Expertise in
24
conditions
Dr. Randolph Del Castillo Senining
Infectious Disease

Randolph Senining

6501 Truxtun Ave, 
Bakersfield, CA 
 (82.3 miles away)
661-322-2206
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Randolph Del Castillo Senining is an Infectious Disease provider in Bakersfield, California. Dr. Del Castillo Senining is highly rated in 24 conditions, according to our data. His top areas of expertise are Coccidioidomycosis, Strep Throat, Meningitis, and Arachnoiditis.

Frequently Asked Questions about Dr. Franco A. Felizarta

How do I make an appointment with Dr. Franco A. Felizarta?

You can book an appointment with Dr. Franco A. Felizarta by calling their office at 661-324-3128. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Franco A. Felizarta a top-rated expert for Coccidioidomycosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Franco A. Felizarta is classified as an Distinguished expert for Coccidioidomycosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Franco A. Felizarta specialize in?

While Dr. Franco A. Felizarta is a Infectious Disease, they have specific expertise in Coccidioidomycosis, HIV/AIDS, and Hepatitis C. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Franco A. Felizarta participate in research or clinical trials?

Yes. Dr. Franco A. Felizarta has published 27 articles and abstracts on conditions like Coccidioidomycosis. You can view a list of Dr. Franco A. Felizarta's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Franco A. Felizarta accept my insurance?

Dr. Franco A. Felizarta accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 661-324-3128 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Felizarta's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile